Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology

Vall Hebron Institut de Recerca

Institutions of which they are part

Translational Molecular Pathology

Vall Hebron Institut de Recerca

Projects

New therapeutic approaches in head and neck cancer

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea, Jordi Temprana Salvador, Angel García Jiménez, Josep Castellví Vives, Laia Josa Culleré, Marina Bataller Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 183920
Reference: PI20/00556
Duration: 01/01/2021 - 30/06/2025

Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Marta Sese Faustino, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01687
Duration: 01/01/2021 - 31/12/2023

Targeting Myeloid-Derived Suppressor Cells to prevent HIV/STI acquisition

IP: Meritxell Genesca Ferrer
Collaborators: Maria Cristina Centeno Mediavilla, Nuria Laia Rodriguez Mias, Yannick Hoyos Mallecot, Josep Castellví Vives, Laura Mañalich Barrachina, María José Buzón Gómez, Maider Arando Lasagabaster, Desideria Martinez Rascón, Bibiana Planas Ribas, Cristina Mancebo Perez
Funding agency: Fundació La Marató de TV3
Funding: 199685
Reference: 20181410
Duration: 10/05/2019 - 31/12/2022

Estudio de la cooperación clonal (heterogeneidad intratumoral) in vitro e in vivo en carcinomas: papel de los exosomas y estudio de los factores secretados

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI17/02247
Duration: 01/01/2018 - 31/12/2020